Hormone Therapies

In women with type 2 diabetes, the changes in sex-hormone levels, abdominal fat, and insulin metabolism that accompany menopause may represent additional impediments in achieving good glycaemic control. There is evidence that exogenous estrogens might reduce some of these adverse changes.

    Related Conference of Hormone Therapies

    June 20-21, 2018

    27th European Diabetes Congress

    | Rome, Italy
    July 16-17, 2018 Sydney, Australia

    20th Asia Pacific Diabetes Conference

    July 23-24, 2018

    Global Meeting on Diabetes and Endocrinology

    Kuala Lumpur, Malaysia
    August 20-21, 2018

    28th World Congress on Diabetes, Obesity & Heart

    Tokyo, Japan
    September 03-04, 2018

    2nd International Conference on Thyroid and Pregnancy

    Auckland, New Zealand
    September 3-4, 2018

    11th World Congress on Endocrinology and Metabolic Disorders

    Auckland, New Zealand
    September 13-15, 2018

    26th International Diabetes and Healthcare Conference

    Bucharest, Romania
    Sep 14-15, 2018

    World Congress on Endocrinology

    Prague , Czech Republic
    Sep 14-15, 2018

    Euro Diabetes Congress & Expo

    | Prague, Czech Republic
    September 28-29, 2018

    2nd International Conference on Diabetes and Diabetic Nursing Care

    Montreal, Quebec, Canada
    November 26-27, 2018

    13th European Diabetes and Endocrinology Congress

    Dublin, Ireland

    Hormone Therapies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in